Brief: Mendus (previously Immunicum) Announces Financing Commitments Totaling Up To SEK 250 Mln With partners

Mendus AB (publ)

26/08/2022 06:22

Aug 26 (Reuters) - Mendus AB (publ)  IMMUN.ST :
    * ANNOUNCES FINANCING COMMITMENTS TOTALING UP TO SEK 250
MILLION
WITH VAN HERK INVESTMENTS AND NEGMA GROUP
    * FINANCING COMMITMENTS WILL ALLOW CO TO REACH ITS NEXT
CLINICAL
READ-OUTS FROM ONGOING ADVANCE II AND ALISON TRIALS, TO PREPARE
FOR NEXT CLINICAL TRIALS AND TO ESTABLISH PIVOTAL-STAGE AND
COMMERCIAL MANUFACTURING FOR ITS LEAD PROGRAM DCP-001
    * BASED ON COMMITMENT LETTER SIGNED WITH VAN HERK
INVESTMENTS,
COMPANY IS ENTITLED TO RECEIVE FROM VAN HERK INVESTMENTS A
SHAREHOLDER LOAN UP TO A MAXIMUM AMOUNT OF SEK 50 MILLION AT
MARKET-STANDARD CONDITIONS
    * NEGMA HAS COMMITTED TO SUBSCRIBE TO UP TO SEK 200 MILLION
IN
CONVERTIBLE BONDS
    * CONVERTIBLE BONDS CARRY A ZERO COUPON AND WILL BE ISSUED
AT A
SUBSCRIPTION PRICE CORRESPONDING TO THEIR PAR VALUE


Further company coverage:  IMMUN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))